RABL2A

Across TCGA pan-cancer cohorts, RABL2A Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated RABL2A data layer compared with 24 for mass-spec protein and 2 for mass-spec protein.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher RABL2A Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated RABL2A expression acts as an unfavorable survival marker.

UCEC, LIHC, and SKCM are the cancer types where RABL2A Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	III,IV	0.051	0.592	<.001	18	view →
LIHC	DFS	Median	All	0.044	0.553	<.001	6	view →
SKCM	OS	Median	II,III,IV	0.179	0.731	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

RABL2A–UCEC (OS)

Open the UCEC breakdown →